Product Information
OLANZAPINE-FLUOXETINE 12-25 MG is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $9.3447 per EA under NDC 00093550656. Its NADAC has been published 319 times since Jan 22, 2014.
Strength
25; 12 mg/1; mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093550656
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FLUOXETINE HYDROCHLORIDE; OLANZAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA077528On Market Since
6/19/2012
Pharmacological Classes
Price Statistics
The NADAC for OLANZAPINE-FLUOXETINE 12-25 MG has been published 319 times since Jan 22, 2014, and over the history we have for it it has declined 44.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.3447 per EA |
|---|---|
| All-time high | $17.0031 (Aug 13, 2014) |
| All-time low | $6.2827 (Jul 23, 2025) |
| 52-week high | $9.3447 |
| 52-week low | $6.2827 |
| Median price | $13.1290 |
| Average price | $11.6941 |
| Largest weekly change | -48.9% (Dec 19, 2018) |
| Weeks tracked | 319 |
| Tracking since | Jan 22, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Olanzapine and Fluoxetine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of OLANZAPINE-FLUOXETINE 12-25 MG?
The current National Average Drug Acquisition Cost (NADAC) for OLANZAPINE-FLUOXETINE 12-25 MG, manufactured by Teva Pharmaceuticals USA Inc., is $9.3447 per EA (NDC 00093550656), effective Jun 24, 2026.
How has the price of OLANZAPINE-FLUOXETINE 12-25 MG changed over time?
Over the history we have for it, the NADAC for OLANZAPINE-FLUOXETINE 12-25 MG has declined 44.1%. It has been tracked across 319 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for OLANZAPINE-FLUOXETINE 12-25 MG?
Since Jan 22, 2014, the NADAC for OLANZAPINE-FLUOXETINE 12-25 MG has ranged from a low of $6.2827 (Jul 23, 2025) to a high of $17.0031 (Aug 13, 2014), with a median of $13.1290 per EA.
Are there cheaper alternatives to OLANZAPINE-FLUOXETINE 12-25 MG?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of OLANZAPINE-FLUOXETINE 12-25 MG, so no direct lower-cost alternative is listed.
Who manufactures OLANZAPINE-FLUOXETINE 12-25 MG?
OLANZAPINE-FLUOXETINE 12-25 MG (NDC 00093550656) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification